Natacha Telusca, MD
Pain Medicine · Stanford, CANPI 1245557636
Payments from drug & device makers
Across 10 payments — averaging $236.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioventus LLC$2K
- Averitas Pharma Inc.$183
- Vertex$176
- Vertos Medical, Inc.$172
- Amgen$125
- Nalu Medical, Inc.$117
- plus $15 from 1 others
What the payments were for
- Consulting fees$1,57567%
- Food & beverage$78833%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioventus LLC | 2 | $1,575 |
| Averitas Pharma Inc. | 2 | $183 |
| Vertex | 2 | $176 |
| Vertos Medical, Inc. | 1 | $172 |
| Amgen | 1 | $125 |
| Nalu Medical, Inc. | 1 | $117 |
| Masimo Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stimrouter Implantable Kit$1,575
- mild Device Kit$172
- Qutenza$128
- AIMOVIG$125
- JOURNAVX$122
- Nalu Neurostimulation System$117
How this compares
$2,363 in reported general payments places this provider in the 50th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 23 | $3,067 |
| Pregabalin | 66 | $1,505 |
| Gabapentin | 55 | $1,173 |
| Celecoxib | 31 | $851 |
| Oxycodone Hcl | 20 | $745 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $636 |
| Duloxetine Hcl | 14 | $423 |
| Baclofen | 16 | $138 |
| Topiramate | 19 | $105 |
| Meloxicam | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Stanford
- Einar OttestadStanford$367K
- Robert CowanStanford$124K
- Jennifer HahStanford$101K
- Addie PeretzStanford$100K
- Vafi SalmasiStanford$55K
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.